The Asia Pacific Penicillin Drug Market would witness market growth of 4.2% CAGR during the forecast period (2023-2030).
A widely used drug for managing and treating different infections is penicillin. It is an ingredient of the class of medications known as beta-lactam antibiotics, including amoxicillin, ampicillin, and other antibiotics. When susceptible organisms cause bacterial infections, penicillin is often used as a therapy. Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, and other gram-negative bacteria like Neisseria meningitidis are merely some of the microorganisms it is effective against.
Penicillin is offered in various dosage forms, including tablets, capsules, solutions, and injections, to accommodate various administration methods and patient requirements. Different dose forms may be used depending on the type of penicillin and the nation's healthcare system. Penicillin prevents the enzymes necessary for the cross-linking of peptidoglycan, a crucial component of the bacterial cell wall, thereby preventing the formation of bacterial cell walls. By weakening the cell wall, this inhibition causes the bacteria to lyse, which ultimately kills bacteria.
The National Library of Medicine reports that from 12.94 DID in 2018 to 14.45 DID in 2019, China's total antibiotic use across all healthcare settings has increased significantly. The consumption of antibiotics in PHCs exceeded 50%, notably in the central regions (59%–68%). According to the Annual Pharmaceutical Production Statistics Report from the Ministry of Health, Labour, and Welfare ("MHLW") of Japan, the Japanese industry for both over the counter and prescription reached a value of US$109 billion in 2020. The market is predicted to expand in this region due to rising antibiotic usage and advancements in the pharmaceutical sector.
The China market dominated the Asia Pacific Penicillin Drug Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.1 billion by 2030. The Japan market is anticipated to grow at a CAGR of 3.5% during (2023 - 2030). Additionally, The India market would register a CAGR of 4.8% during (2023 - 2030).
Based on Source, the market is segmented into Semisynthetic Penicillin and Natural Penicillin. Based on Spectrum of Activity, the market is segmented into Broad spectrum, Extended spectrum and Narrow spectrum. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Penicillin Drug Market is Projected to reach USD 10.9 Billion by 2030, at a CAGR of 3.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Source
- Semisynthetic Penicillin
- Natural Penicillin
By Spectrum of Activity
- Broad spectrum
- Extended spectrum
- Narrow spectrum
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Route of Administration
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Novartis AG
- Lupin Limited
- Abbott Laboratories
- Cipla Limited
- Takeda Pharmaceutical Company Limited
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Penicillin Drug Market, by Source
1.4.2 Asia Pacific Penicillin Drug Market, by Spectrum of Activity
1.4.3 Asia Pacific Penicillin Drug Market, by Distribution Channel
1.4.4 Asia Pacific Penicillin Drug Market, by Route of Administration
1.4.5 Asia Pacific Penicillin Drug Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Asia Pacific Penicillin Drug Market by Source
5.1 Asia Pacific Semisynthetic Penicillin Market by Country
5.2 Asia Pacific Natural Penicillin Market by Country
Chapter 6. Asia Pacific Penicillin Drug Market by Spectrum of Activity
6.1 Asia Pacific Broad spectrum Market by Country
6.2 Asia Pacific Extended spectrum Market by Country
6.3 Asia Pacific Narrow spectrum Market by Country
Chapter 7. Asia Pacific Penicillin Drug Market by Distribution Channel
7.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
7.2 Asia Pacific Hospital Pharmacies Market by Country
7.3 Asia Pacific Online Providers Market by Country
Chapter 8. Asia Pacific Penicillin Drug Market by Route of Administration
8.1 Asia Pacific Parenteral Market by Country
8.2 Asia Pacific Oral Market by Country
Chapter 9. Asia Pacific Penicillin Drug Market by Country
9.1 China Penicillin Drug Market
9.1.1 China Penicillin Drug Market by Source
9.1.2 China Penicillin Drug Market by Spectrum of Activity
9.1.3 China Penicillin Drug Market by Distribution Channel
9.1.4 China Penicillin Drug Market by Route of Administration
9.2 Japan Penicillin Drug Market
9.2.1 Japan Penicillin Drug Market by Source
9.2.2 Japan Penicillin Drug Market by Spectrum of Activity
9.2.3 Japan Penicillin Drug Market by Distribution Channel
9.2.4 Japan Penicillin Drug Market by Route of Administration
9.3 India Penicillin Drug Market
9.3.1 India Penicillin Drug Market by Source
9.3.2 India Penicillin Drug Market by Spectrum of Activity
9.3.3 India Penicillin Drug Market by Distribution Channel
9.3.4 India Penicillin Drug Market by Route of Administration
9.4 South Korea Penicillin Drug Market
9.4.1 South Korea Penicillin Drug Market by Source
9.4.2 South Korea Penicillin Drug Market by Spectrum of Activity
9.4.3 South Korea Penicillin Drug Market by Distribution Channel
9.4.4 South Korea Penicillin Drug Market by Route of Administration
9.5 Singapore Penicillin Drug Market
9.5.1 Singapore Penicillin Drug Market by Source
9.5.2 Singapore Penicillin Drug Market by Spectrum of Activity
9.5.3 Singapore Penicillin Drug Market by Distribution Channel
9.5.4 Singapore Penicillin Drug Market by Route of Administration
9.6 Malaysia Penicillin Drug Market
9.6.1 Malaysia Penicillin Drug Market by Source
9.6.2 Malaysia Penicillin Drug Market by Spectrum of Activity
9.6.3 Malaysia Penicillin Drug Market by Distribution Channel
9.6.4 Malaysia Penicillin Drug Market by Route of Administration
9.7 Rest of Asia Pacific Penicillin Drug Market
9.7.1 Rest of Asia Pacific Penicillin Drug Market by Source
9.7.2 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity
9.7.3 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel
9.7.4 Rest of Asia Pacific Penicillin Drug Market by Route of Administration
Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Sun Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 GlaxoSmithKline PLC (GSK)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.5.3 Trials and Approvals:
10.5.6 SWOT Analysis
10.6 Lupin Limited
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Recent strategies and developments:
10.6.3.1 Partnerships, Collaborations, and Agreements:
10.6.4 SWOT Analysis
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 Cipla Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Acquisition and Mergers:
10.8.6 SWOT Analysis
10.9 Alkem Laboratories Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Product Launches and Product Expansions:
10.9.6 SWOT Analysis
10.10. Takeda Pharmaceutical Company Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Acquisition and Mergers:
10.10.6 SWOT Analysis
TABLE 1 Asia Pacific Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Penicillin Drug Market
TABLE 4 Product Launches And Product Expansions– Penicillin Drug Market
TABLE 5 Acquisition and Mergers– Penicillin Drug Market
TABLE 6 Trials and Approvals- Penicillin Drug Market
TABLE 7 Asia Pacific Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Natural Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Natural Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Broad spectrum Market by Country, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Broad spectrum Market by Country, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Extended spectrum Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Extended spectrum Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Narrow spectrum Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Narrow spectrum Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 27 Asia Pacific Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 Asia Pacific Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 29 Asia Pacific Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 30 Asia Pacific Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 31 Asia Pacific Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 32 Asia Pacific Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 33 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
TABLE 34 Asia Pacific Oral Market by Country, 2023 - 2030, USD Million
TABLE 35 Asia Pacific Penicillin Drug Market by Country, 2019 - 2022, USD Million
TABLE 36 Asia Pacific Penicillin Drug Market by Country, 2023 - 2030, USD Million
TABLE 37 China Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 38 China Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 39 China Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 40 China Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 41 China Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 42 China Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 43 China Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 China Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 China Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 China Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 Japan Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 48 Japan Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 49 Japan Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 50 Japan Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 51 Japan Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 52 Japan Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 53 Japan Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 Japan Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 Japan Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Japan Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 India Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 58 India Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 59 India Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 60 India Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 61 India Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 62 India Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 63 India Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 India Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 India Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 India Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 South Korea Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 68 South Korea Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 69 South Korea Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 70 South Korea Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 71 South Korea Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 72 South Korea Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 73 South Korea Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 South Korea Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 South Korea Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 South Korea Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 Singapore Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 78 Singapore Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 79 Singapore Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 80 Singapore Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 81 Singapore Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 82 Singapore Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 83 Singapore Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Singapore Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Singapore Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 Singapore Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 Malaysia Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 88 Malaysia Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 89 Malaysia Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 90 Malaysia Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 91 Malaysia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 92 Malaysia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 93 Malaysia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Malaysia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 95 Malaysia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 96 Malaysia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 97 Rest of Asia Pacific Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 98 Rest of Asia Pacific Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 99 Rest of Asia Pacific Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 100 Rest of Asia Pacific Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 101 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 102 Rest of Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 103 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 104 Rest of Asia Pacific Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 105 Rest of Asia Pacific Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Rest of Asia Pacific Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Key Information – Novartis AG
TABLE 108 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 109 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 110 Key Information – GlaxoSmithKline PLC
TABLE 111 Key Information – Pfizer, Inc.
TABLE 112 Key Information – Lupin Limited
TABLE 113 Key Information – Abbott Laboratories
TABLE 114 Key Information – Cipla Limited
TABLE 115 Key Information – Alkem Laboratories Ltd.
TABLE 116 Key Information – Takeda Pharmaceutical Company Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Penicillin Drug Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Penicillin Drug Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
FIG 7 Porter’s Five Forces Analysis – Penicillin Drug Market
FIG 8 Asia Pacific Penicillin Drug Market share by Source, 2022
FIG 9 Asia Pacific Penicillin Drug Market share by Source, 2030
FIG 10 Asia Pacific Penicillin Drug Market by Source, 2019 - 2030, USD Million
FIG 11 Asia Pacific Penicillin Drug Market share by Spectrum of Activity, 2022
FIG 12 Asia Pacific Penicillin Drug Market share by Spectrum of Activity, 2030
FIG 13 Asia Pacific Penicillin Drug Market by Spectrum of Activity, 2019 - 2030, USD Million
FIG 14 Asia Pacific Penicillin Drug Market share by Distribution Channel, 2022
FIG 15 Asia Pacific Penicillin Drug Market share by Distribution Channel, 2030
FIG 16 Asia Pacific Penicillin Drug Market by Distribution Channel, 2019 - 2030, USD Million
FIG 17 Asia Pacific Penicillin Drug Market share by Route of Administration, 2022
FIG 18 Asia Pacific Penicillin Drug Market share by Route of Administration, 2030
FIG 19 Asia Pacific Penicillin Drug Market by Route of Administration, 2019 - 2030, USD Million
FIG 20 Asia Pacific Penicillin Drug Market share by Country, 2022
FIG 21 Asia Pacific Penicillin Drug Market share by Country, 2030
FIG 22 Asia Pacific Penicillin Drug Market by Country, 2019 - 2030, USD Million
FIG 23 SWOT Analysis: Novartis AG
FIG 24 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 26 SWOT Analysis: GlaxoSmithKline PLC
FIG 27 Recent strategies and developments: Pfizer, Inc.
FIG 28 SWOT Analysis: Pfizer, Inc.
FIG 29 SWOT Analysis: Lupin Limited
FIG 30 SWOT Analysis: Abbott Laboratories
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Alkem Laboratories Ltd.
FIG 33 SWOT Analysis: Takeda Pharmaceutical Company Limited